↓ Skip to main content

Nuclear and cytoplasmic LIMK1 enhances human breast cancer progression

Overview of attention for article published in Molecular Cancer, June 2011
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (65th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (53rd percentile)

Mentioned by

twitter
1 X user
patent
5 patents

Readers on

mendeley
40 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Nuclear and cytoplasmic LIMK1 enhances human breast cancer progression
Published in
Molecular Cancer, June 2011
DOI 10.1186/1476-4598-10-75
Pubmed ID
Authors

Brice V McConnell, Karen Koto, Arthur Gutierrez-Hartmann

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 40 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 5%
Finland 1 3%
Germany 1 3%
Belgium 1 3%
Unknown 35 88%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 10 25%
Researcher 7 18%
Student > Bachelor 4 10%
Other 3 8%
Student > Postgraduate 3 8%
Other 6 15%
Unknown 7 18%
Readers by discipline Count As %
Agricultural and Biological Sciences 17 43%
Biochemistry, Genetics and Molecular Biology 7 18%
Medicine and Dentistry 3 8%
Immunology and Microbiology 1 3%
Pharmacology, Toxicology and Pharmaceutical Science 1 3%
Other 2 5%
Unknown 9 23%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 October 2020.
All research outputs
#7,132,041
of 23,294,050 outputs
Outputs from Molecular Cancer
#507
of 1,757 outputs
Outputs of similar age
#38,691
of 115,581 outputs
Outputs of similar age from Molecular Cancer
#6
of 15 outputs
Altmetric has tracked 23,294,050 research outputs across all sources so far. This one has received more attention than most of these and is in the 68th percentile.
So far Altmetric has tracked 1,757 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.9. This one has gotten more attention than average, scoring higher than 69% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 115,581 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 65% of its contemporaries.
We're also able to compare this research output to 15 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 53% of its contemporaries.